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Abstract: TRPA1 is a ligand-activated cation channel found in the intestine and other tissues.
Components of food that stimulate TRPA1 receptors (phytonutrients) include allyl isothiocyanate,
cinnamaldehyde and linalool, but these may also act at other receptors. Cells lining the intestinal
mucosa are immunoreactive for TRPA1 and Trpa1 mRNA occurs in mucosal extracts, suggesting
that the TRPA1 receptor is the target for these agonists. However, in situ hybridisation reveals
Trpa1 expression in 5-HT containing enteroendocrine cells, not enterocytes. TRPA1 agonists evoke
mucosal secretion, which may be indirect (through release of 5-HT) or direct by activation of
enterocytes. We investigated effects of the phytonutrients on transmucosal ion currents in mouse
duodenum and colon, and the specificity of the phytonutrients in cells transfected with Trpa1, and in
Trpa1-deficient mice. The phytonutrients increased currents in the duodenum with the relative
potencies: allyl isothiocyanate (AITC) > cinnamaldehyde > linalool (0.1 to 300 µM). The rank order
was similar in the colon, but linalool was ineffective. Responses to AITC were reduced by the TRPA1
antagonist HC-030031 (100 µM), and were greatly diminished in Trpa1−/− duodenum and colon.
Responses were not reduced by tetrodotoxin, 5-HT receptor antagonists, or atropine, but inhibition
of prostaglandin synthesis reduced responses. Thus, functional TRPA1 channels are expressed by
enterocytes of the duodenum and colon. Activation of enterocyte TRPA1 by food components has the
potential to facilitate nutrient absorption.
Keywords: micronutrients; enteroendocrine cells; intestine; serotonin; transepithelial transport;
transient receptor potential A1
1. Introduction
Herbs or herb-derived chemicals (collectively, phytonutrients) are used in very small amounts
(parts per million, i.e., grams per tonne) to flavour food and, in animal feed, and are proposed
to improve efficiency of nutrient digestion [1–5]. Several of these herbs contain compounds that
activate transient receptor potential ankyrin 1 (TRPA1) channels. These include cinnamaldehyde from
cinnamon, allyl isothiocyanate (AITC), which is a pungent component in mustard, radish, horseradish
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and wasabi, and linalool, which is found in many plant species, including mints, laurels and citrus
fruits, but is not pungent [6–8]. TRPA1 is also activated by polyunsaturated fatty acids [9]. A site of
exposure to these food components is the mucosal lining of the gastrointestinal tract. While TRPA1
expression has largely been associated with sensory nerves, and it has roles in pain sensation and
inflammation, the receptor is also expressed on a multitude of non-neuronal sites, leading to ongoing
investigations into its non-nociceptive functions. TRPA1 is a non-selective cation channel whose
opening depolarises cells and permits calcium entry [10]. Thus, TRPA1 agonists in food would be
expected to change ion currents across the mucosa if functional TRPA1 channels are expressed in
the mucosal epithelium. TRPA1 mRNA has been detected by RT-PCR in colonic crypts in rat [11],
in extracts of the duodenal, ileal and colonic mucosa of mouse [12,13] and in mouse and human
duodenal mucosa [14]. It has been detected by immunohistochemistry in the surface epithelium of the
rat colon [11] and mouse small intestine and colon [12]. TRPA1 channels have also been reported in
enteroendocrine (EEC) cells of the human, rat, and mouse intestine, with most of the Trpa1-expressing
cells being immunoreactive for 5-hydroxytryptamine (5-HT) [13,15]. AITC caused 5-HT release from
isolated EEC and from a pancreas-derived enterochromaffin cell line [15].
TRPA1 agonists increase ion secretion in the pig small intestine [16], and the rat and human
colon [12], in each case the effect being resistant to the blocking of nerve conduction with tetrodotoxin
(TTX), which therefore appears to be a direct effect of the agonists on the mucosal epithelium. However,
AITC, cinnamaldehyde, linalool and other plant-derived stimulants of TRPA1 receptors lack specificity,
an example being the immune-suppressant effect of cinnamaldehyde through the inhibition of toll-like
receptor 4 [17], and whether their effects on ion secretion are mediated through TRPA1 has not
been investigated.
In order to gain further insight into the intestinal effects of food components that act at TRPA1
ligand-gated ion channels, we have compared the effects of cinnamaldehyde, AITC and linalool on
mucosal ion transport in the small intestine and colon from normal and Trpa1 knockout mice and on




Male C57Bl/6 wild-type mice, aged eight to 10 weeks, were housed in the Biomedical Animal
Facility at the University of Melbourne. Trpa1-deleted mice and Trpa1+/+ colony-matched mice on
a C57Bl/6 background [18] were housed in the Monash Animal Research Platform. The animals
were provided standard chow and water ad libitum. National Health and Medical Research Council
of Australia (NHMRC) ethics guidelines were followed and the procedures were approved by the
University of Melbourne Animal Ethics Committee (ethical approval code No. 1312777).
2.2. Ussing Chamber Experiments
Isoflurane was used to anaesthetise the mice; carotid arteries and spinal cord were then severed.
Distal colon and duodenum segments were removed, opened along the mesenteric border and pinned,
with the external muscle included, onto Ussing chamber sliders (P2311, 0.3 cm2 apertures, Physiological
Instruments, San Diego, CA, USA) in physiological saline (Krebs’ solution: 11.1 mM glucose, 118 mM
NaCl, 4.8 mM KCl, 1.0 mM NaH2PO4, 1.2 mM MgSO4, 25 mM NaHCO3, 2.5 mM CaCl2, pH 7.4).
The sliders were inserted into two-part chambers (EasyMount Diffusion Chambers, Physiologic
Instruments) and 5 mL Krebs’ solution was added to both sides, with the mucosal Krebs’ solution
containing 11.1 mM mannitol instead of glucose. The glucose is required as an energy substrate, but is
replaced with mannitol in the mucosal solution to restrict active transport while maintaining osmotic
balance. Solutions were kept at 37 ◦C and gassed with carbogen (5% CO2, 95% O2) to maintain pH.
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A multichannel voltage-current clamp (VCC MC6, Physiologic Instruments) was linked to each
chamber through a set of four electrodes (2 voltage sensing and 2 current passing electrodes) and agar
bridges (3% agarose/3 M KCl in the tip and backfilled with 3 M KCl) installed on opposite sides of
the tissue. Voltage and Isc readings were acquired using a PowerLab amplifier and recorded using
LabChart® 5 (both ADInstruments, Sydney, Australia).
Tissue was left to equilibrate for 30 min before clamping the voltage to 0 V. Epithelial resistance
(Ω·cm2) was determined from the Isc/voltage relationship by administering 2 s pulses of 2 mV every
60 s throughout most experiments and measuring the current changes.
Concentration response curves were created by consecutively adding increasing concentrations
(100 nM up to 300 µM) of TRPA1 agonists (AITC, cinnamaldehyde and linalool) to the mucosal side of
the Ussing chamber. The mucosal chamber was washed 4 min after the addition of the agonist, or when
the response plateaued. Antagonists (HC-030031, granisetron, SB-204070, atropine, indomethacin and
TTX) were added 20 min prior to the addition of a single dose of AITC (100 µM). With the exception of
the TRPA1 antagonist (HC-030031), which was added to the mucosal bath, and indomethacin, which
was added to both the serosal and mucosal baths, these antagonists were applied to the serosal bath.
Chambers were washed after 4 min, or when the AITC response plateaued, and again 5 min later.
In order to measure the time course of AITC response, a separate set of experiments was done with
a single dose of AITC (100 µM) added to the mucosal bath and not washed out.
Carbachol (100 µM) was added to the serosal bath at the end of every experiment to assess the
condition of the tissue. Results were excluded if the carbachol response was less than 10 µA·cm−2,
which is less than baseline fluctuations that were observed. Drug-induced resistance responses are
presented as changes from values before drug administration.
2.3. Calcium Mobilisation Assay
HEK293 cells expressing rat Trpa1 (HEK-TRPA1 cells) as previously described [19] were used.
The cells were grown in Dulbecco’s modified Eagle’s medium (DMEM; Sigma-Aldrich, Sydney,
Australia) containing 10% tetracycline free fetal bovine serum, 100 U·mL−1 penicillin, 100 µg·mL−1
streptomycin and 50 µg·mL−1 hygromycin B. To induce TRPA1 channel expression, tetracycline
(0.1 µg·mL−1) was added to the medium 18 h before use. Non-transfected HEK293 cells, cultured
without hygromycin B, were used as negative controls. Cells were grown at 37 ◦C with 5% CO2.
For calcium measurements, cells were incubated with 2.5 µM Fura2-AM (Invitrogen, Sydney,
Australia) and pluronic acid (Invitrogen; 0.01%) in HEPES buffer (138 mM NaCl, 5 mM KCl, 1.2 mM
MgCl2, 2 mM CaCl2, 10 mM glucose, 10 mM HEPES, pH 7.4) for 1 h at 37 ◦C. A FlexStation three-plate
reader (Molecular Devices, Sunnyvale, CA, USA), was used to dispense TRPA1 agonists and monitor
changes in intracellular Ca2+. Fluorescence was measured (4 s intervals) at 340 nm and 380 nm
excitation and 510 nm emission wavelengths for 120 s.
Agonists were added at 15 s, and antagonists were pre-incubated 20 min before the addition of
the agonist. Data were recorded using SoftMax Pro® 5.4. The mean of the peak fluorescence ratio
after agonist injection minus the basal ratio was used for plotting concentration response curves as
previously described [20].
2.4. Compounds
AITC, cinnamaldehyde, linalool, carbachol, indomethacin, TTX, atropine and SB-204070 were
purchased from Sigma-Aldrich (Sydney, Australia). Granisetron was from SmithKline Beecham,
Harlow, UK and HC-030031 was from Sapphire Biosciences, Melbourne, Australia. TRPA1 agonists
(AITC, cinnamaldehyde and linalool) and TRPA1 antagonist (HC-030031) stock solutions were
dissolved in dimethyl sulfoxide (DMSO; maximum final volume 0.3%). Stock solutions of the
remaining compounds were made with distilled water. Further dilutions were made with HEPES
buffer for calcium mobilisation experiments and distilled water and Krebs’ solution for Ussing
chamber experiments.
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2.5. Data Analysis
Data from both the Ussing and calcium mobilisation concentration-response experiments are
presented as linear regression curves. A one-way ANOVA was used when comparing three or
more experimental groups, using a Dunnetts’ post hoc test to compare groups to the vehicle control.
An unpaired t-test was performed when comparing two groups.
pA2 values were calculated from concentrations of antagonists that did not depress the maximum
agonist response using the Gaddum/Schild EC50 shift analysis using GraphPad Prism 5.0 (Graph-Pad
Software, San Diego, CA, USA). Data are presented as mean ± SEM. Significance was set at p < 0.05.
3. Results
3.1. Effects of AITC, Cinnamaldehyde and Linalool on Ca2+ Mobilisation in HEK-TRPA1 Cells
AITC, cinnamaldehyde and linalool increased cytoplasmic Ca2+ in HEK-TRPA1 cells but not
in non-transfected HEK293 cells (Figure 1A, data not shown for cinnamaldehyde and linalool on
non-transfected HEK293 cells). The most potent agonist at 100 µM was AITC (0.36 ± 0.10 increase in
∆Fura-2 ratio, n = 5). The calcium response to cinnamaldehyde (100 µM) was 87% ± 22% of the AITC
response (n = 4), and to linalool (100 µM) was 32% ± 7% (n = 5) of the AITC response. The TRPA1
antagonist HC-030031 (100 µM), added to the cells at least 20 min before AITC, produced a rightward
shift in the concentration response curves in HEK-TRPA1 cells (Figure 1B; response at 100 µM AITC
plus HC-030031 was 65% ± 15% of AITC alone, n = 5). At 10 and 30 µM, HC-030031 had a minimal
effect on the AITC response curve (Figure 1B; response at 100 µM AITC was 107% ± 15%, n = 4 and
102% ± 20%, n = 4 of the response to AITC alone, respectively). The calculated pA2 for HC-030031
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Isc  was  6.02  ±  0.59  μA∙cm−2  (n  =  106).  TRPA1  agonists,  applied  to  the mucosal  side  of mouse 
duodenum and colon  tissue mounted  in Ussing chambers, caused  transient  increases  in  the short 
circuit current (Figure 2). Responses to AITC (100 μM) were greater in magnitude in the colon (58.7 ± 
5.1 μA∙cm−2, n = 11) than in the duodenum (21.4 ± 3.3 μA∙cm−2, n = 13). Responses to 100 μM AITC 
Figure 1. Concentration-response relationships for TRPA1 agonists and the effect of a TRPA1 receptor
antagonist on HEK393 cells transfected with the Trpa1 gene. (A) Calcium mobilisation (expressed as
∆ Fura-2 ratio) in response to allyl isothiocyanate (AITC), cinnamaldehyde (CMA) and linalool (LL);
(B) The inhibitory effect of graded concentrations of HC-030031 ( C) on the response to AITC in the
transfected cells. Neither the agonists nor the antagonist had any effect in the HEK293 cells that were
not transfected with Trpa1, indicated by AITC (non-T cells) in (A). The weak effect of linalool is reflected
in the studies of mucosal function.
3.2. Effects of AITC, Cinnamaldehyde and Linalool on Short Circuit Current (Isc)
In these experiments, the basal resistance in the duodenum was 61.6 ± 0.8 Ω·cm2 and the basal
Isc was 3.65 ± 0.38 µA·cm−2 (n = 122). In the colon, the basal resistance was 114.0 ± 2.3 Ω·cm2 and
the basal Isc was 6.02 ± 0.59 µA·cm−2 (n = 106). TRPA1 agonists, applied to the mucosal side of
mouse duodenum and colon tissue mounted in Ussing chambers, caused transient increases in the
short circuit current (Figure 2). Responses to AITC (100 µM) were greater in magnitude in the colon
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(58.7 ± 5.1 µA·cm−2, n = 11) than in the duodenum (21.4 ± 3.3 µA·cm−2, n = 13). Responses to 100 µM
AITC peaked between 1 and 1.4 min in the duodenum (n = 4) and 2 and 6.7 min in the colon (n = 7;
Figure 2). These responses declined to 50% at 2.3 to 2.6 min and at 4.6 to 9.0 min after adding AITC to
the duodenum and colon, respectively. Small, brief, transient decreases in Isc were sometimes observed,
prior to the increased Isc, following the addition of AITC, cinnamaldehyde, and linalool, 100 to 300 µM,

















Figure 3. Concentration‐response  relationships  for TRPA1 agonists on Trpa1+/+ and  −/−  tissues  in 
Ussing  chambers. Change  in  short  circuit  current  (Isc)  in  response  to  allyl  isothiocyanate  (AITC), 
cinnamaldehyde (CMA) and  linalool (LL) in wild‐type mouse duodenum (A) and distal colon (B); 
Change  in Isc  in response to AITC  in duodenum (C) and distal colon (D) from Trpa1 −/− mice and 
Trpa1 +/+ mice from the same colony. 
Figure 2. Representative traces of the short cir it rrent (Isc) following addition of AITC (100 µM).
AITC was added to the mucosal side of the Ussing chamber mounted with wild-type mouse duodenum
(A) and distal colon (B).
In cumulative concentration response determinations, the most potent agonist at 100 µM in the
duodenum was AITC (21.4 ± 3.3 µA·cm−2, n = 13), then cin amaldehyde ( .2 ± 3.1 µA·cm−2, n = 7)
and then l alool (2.3 ± 1.1 µA·cm−2, n = 6) (Figure 3A). In he colo only AITC (58.7 ± 5.1 µA·cm−2,
n = 11) and cinnamaldehyde (32.5 ± 0.4 µA·cm−2, n = 8) were potent, with linalool having no effect
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Figure 3. Concentration-response relationships for TRPA1 agonists on Trpa1+/+ and −/− tissues
in Ussing chambers. Change in short circuit current (Isc) in response to allyl isothiocyanate (AITC),
cinnamaldehyde (CMA) and linalool (LL) in wild-type mouse duodenum (A) and distal colon (B);
Change in Isc in response to AITC in duodenum (C) and distal colon (D) from Trpa1 −/− mice and
Trpa1 +/+ mice from the same colony.
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3.3. Effects of Pharmacological Antagonism and Ablation of Trpa1 on Responses to AITC
In the presence of the TRPA1 antagonist, HC-030031 (100 µM), Isc responses to AITC (100 µM)
were significantly reduced in both the duodenum (18.3 ± 5.1 µA·cm−2, n = 6, to 0.41 ± 0.12 µA·cm−2,









μM)  in  both  the duodenum  (A)  and  colon  (B).  ***  p <  0.01;  **  p <  0.05. DMSO  is  the vehicle  for 
dissolving HC‐030031. 


















Figure 6B), whereas  it caused a small significant  increase  in resistance in the duodenum (3.2 ± 0.7 
Ω∙cm2, equivalent to 5.2% ± 1.2% of the initial resistance, n = 13; p < 0.05; Figure 6A). No other groups 
Figure 4. The TRPA1 receptor t onist, HC- 30031 (HC; 100 µM), reduc d the effects of AITC
(100 µ ) in both the duodenum (A) and colon (B). *** p < 0.01; ** p < 0.05. DMSO is the vehicle for
dissolving HC-030031.
AITC (300 µM) was significantly less potent in Trpa1−/− tissues compared to controls in the
duodenum (Trpa1 /+: 11.4 ± 5.2 µA·cm−2, n = 4; Trpa1−/−: 0.9 ± 0. 8 µA·cm−2, n = 6; p < 0.05) and
in the colon (Trpa1+/+: 38.3 ± 3.6 µA·c −2, n = 3; Trpa1−/−: 3.0 ± 2.1 µA·cm−2, n = 4; p < 0.001)
(Figure 3C,D). In these experim nts, ffects in tissues from th wild-type mice (Trpa1+/+ mice) from the
same breeding colony as the Trpa1−/− ice were used for comparison. Responses in the duodenum
from these colony-matched Trpa1+/+ mice were smaller than in the C57Bl6 mice used in the remainder
of this study.
Representative traces of the response to AITC following incubation with HC-030031, and also in








μM)  in  both  the duodenum  (A)  and  colon  (B).  ***  p <  0.01;  **  p <  0.05. DMSO  is  the vehicle  for 
dissolving HC‐030031. 


















Figure 6B), whereas  it caused a small significant  increase  in resistance in the duodenum (3.2 ± 0.7 
Ω∙cm2, equivalent to 5.2% ± 1.2% of the initial resistance, n = 13; p < 0.05; Figure 6A). No other groups 
Figure 5. Representative traces of the Isc following addition of AITC (100 µM) to duodenum (A,B) and
colon (C,D) segments. (A,C) AITC was added after 20 min incubation with either DMSO (control) or
HC-030031 (100 µM; antagonist); (B,D) AITC was added to Trpa1+/+ control tissue and Trpa1−/−
tissues. Arrowheads: AITC (100 µM) added to mucosal solution. The transients that appear in these
records were the responses to current pulses used to measure trans-epithelial resistance.
3.4. Effects of AITC, Cinnamaldehyde and Linalool on Transmucosal Resistance
AITC (100 µM) caused a significant decrea e in r sistance in the colon compared to the vehicle
(−21.8 ± 1.9 Ω·cm2, equivalent to decreasing the initial resistance by 19.0% ± 1.7%, n = 11;
p < 0.001; Figure 6B), whereas it caused a small significant increase in resistance in the duodenum
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(3.2 ± 0.7 Ω·cm2, equivalent to 5.2% ± 1.2% of the initial resistance, n = 13; p < 0.05; Figure 6A).
No other groups were significantly different to the vehicle in the duodenum. The order of efficacy
of TRPA1 agonists in reducing transmucosal resistance in the colon was the same as the order of
efficacy for the change in Isc. Cinnamaldehyde (100 µM) caused a significant reduction in resistance
(−14.0 ± 2.3 Ω·cm2, n = 8; p < 0.01), and linalool (100 µM) had little effect (4.4 ± 1.1 Ω·cm2, n = 6;
Figure 6B). The reduction in resistance in response to 100 µM AITC (−19.2 ± 3.4 Ω·cm2, n = 7)
in the colon was significantly lower when the tissue was pre-incubated with 100 µM HC-030031
(−8.0 ± 2.7 Ω·cm2, n = 5; p < 0.0001), and the effect of AITC on resistance in the colon of Trpa1+/+
mice (−18.8 ± 0.6 Ω·cm2, n = 3) was absent in Trpa1−/− tissues (−2.5 ± 0.9 Ω·cm2, n = 4; p < 0.05).
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Figure 6. Transmucosal resistance in the first 4 min following the addition of AITC (100 µM).
Co parison of the effect of AITC only, AITC following pre-incubation with HC-030031 (100 µ ;
HC), and AITC in Trpa1−/− tissues of mouse duodenum (A) and distal colon (B).
3.5. Effects of 5-HT Receptor Blockers, Tetrodotoxin, Atropine and Indomethacin
Responses to AITC (100 µM) in the presence of the 5-HT3 receptor antagonist granisetron (1 µM;
n ≥ 6), the 5-HT4 receptor antagonist SB-204070 (1 µM; n ≥ 8), the muscarinic acetylcholine receptor
antagonist atropine (10 µM; n = 6), or the sodium channel blocker TTX (1 µM; n ≥ 7) were not
significantly different to AITC alone (100 µM; n = 16) in either the duodenum or the colon (Figure 7).
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Figure 7. Effect of AITC (100 µM) on Isc following a 20 min incubation period with antagonist in mouse
duodenum (A) and colon (B). Tissues were incubated with granisetron, SB-204070, TTX, atropine and
their vehicle (5 µL dH2O) for 20 min. No change in Isc was observed in response to the AITC vehicle
(5 µL DMSO) after a 20 min incubation with 5 µL added water (data not shown). No statistically
significant difference as found bet een experimental groups using a one-way ANOVA.
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The prostaglandin synthase inhibitor indomethacin (10 µM) significantly reduced responses in the
duodenum (28.7 ± 8.2 µA·cm−2, n = 7, to 7.6 ± 4.2 µA·cm−2, n = 7; p < 0.05) and reversed the effect of
AITC from an increase to a decrease in the colon (30.8 ± 5.3 µA·cm−2, n = 7, to −27.4 ± 4.1 µA·cm−2,
n = 4; p < 0.0001) (Figure 8). Representative traces are shown in Figure 8C,D.Nutrients 2016, 8, 623  8 of 11 
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4. Discussion
Three plant-derived TRP 1 agonists, allyl isothiocyanate ( IT ), cinna aldehyde, and linalool,
hich are co only used as food additives, all caused increases in the short circuit current in the
duodenu and colon of the ouse hen applied to the lu inal surface. The ost potent of these,
IT , as used to investigate the specificity of the effect. Its action as antagonised by the T P 1
antagonist -030031, and as almost completely absent in the duodenum and colon of Trpa1−/−
ice. This indicates that the agonists act through TRP 1 receptors to sti ulate transepithelial ion
transport, hich is linked to fluid ove ent across the epitheliu [21,22]. The residual response in
the colon of Trpa1−/− mice indicates that a small component of AITC action is not through the TRP 1
receptor. Sti ulation of ion transport can be through a direct effect on the epitheliu , or indirectly,
for example through the release of hormones from EEC. Hormones, such as 5-HT, could in turn activate
secretomotor neurons. We have previously found that Trpa1 gene transcripts are expressed by 5-HT
containing EEC in the duodenum, but not in the colon [13]. Other studies have detected TRPA1 protein
by immunohistochemistry in enterocytes of the mucosal epithelium of the small intestine and colon of
the mouse [12] and the colon of the rat [11]. 5-HT released from the EEC acts indirectly, through 5-HT3
and 5-HT4 receptors that stimulate mucosal nerve endings and activate secretomotor neurons [23,24].
Action potential conduction in these neurons is blocked by TTX [23]. Thus, if stimulation of mucosal
secretion is indirect through 5-HT release from EEC and neural activation, it would be expected to
be blocked by TTX and to be reduced by the 5-HT3 and 5-HT4 receptor antagonists, granisetron and
SB-204070. However, none of these compounds caused any reduction of responses in the duodenum
or colon. We therefore conclude that the increases in Isc are caused by actions on enterocytes and
that these actions are not indirect through activation of enteric neurons or release and action of 5-HT.
As mentioned, enterocytes show immunoreactivity for TRPA1, but we did not find gene expression in
these cells using in situ hybridisation [13]. It is feasible that the level of expression of the gene product
and turnover of the receptor is low, and thus the amount of mRNA in individual enterocytes is below
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the level of detection by in situ hybridisation. However, RT-PCR reveals Trpa1 gene expression in
the duodenal and colonic mucosa of the mouse [12,13]. Thus, the present pharmacological and gene
knockout data is consistent with immunohistochemical and RT-PCR observations, and allows us to
conclude that there are functional TRPA1 channels on enterocytes in the mouse.
The effects of the TRPA1 agonists were reduced by the prostaglandin synthase inhibitor
indomethacin, which confirms the results of Kaji et al. [11], who found that AITC-evoked secretion was
reduced by piroxicam and a prostaglandin EP4 receptor antagonist. These results suggest that TRPA1
agonists stimulate prostaglandin production in the mucosa. Effects of histamine and reflexly-evoked
secretion are also reduced by indomethacin [25,26]. Thus, prostaglandins might be intermediates in
responses of the mucosa to a range of stimuli. In some cases, but only in the duodenum, the direction
of the Isc change was reversed after indomethacin. It is likely that this decrease in Isc is a response to
TRPA1 activation, because it occurred with all three agonists, but these occasional responses have not
been investigated further.
TRPA1 can closely associate with TRPV1, for example in sensory neurons [27], and TRPV1 ligands
can change the properties of the associated TRPA1 channel, tending to reduce its opening. Thus,
TRPV1 agonists that occur in foods, for example capsaicin, may reduce TRPA1-mediated increases in
secretion. However, these potential interactions have yet to be investigated in the intestine.
AITC and cinnamaldehyde decreased trans-mucosal resistance in colon tissue. This effect was
blocked by HC-030031 and was absent in duodenal segments and in colon tissue from Trpa1 knockout
mice. Kaji and colleagues observed a similar increase in transepithelial conductance in the rat
colon but not the human colon, following AITC and cinnamaldehyde, which was also inhibited
by HC-030031 [10]. The underlying reason for the changes in conductance in some tissues and not
others in response to TRPA1 activation is currently undetermined.
This study has verified that activation of TRPA1 channels in a recombinant system (HEK293
cells) causes an increase in the intracellular calcium concentration. Nozawa and colleagues have
also shown that activation of endogenous TRPA1 channels mediates an influx of extracellular
calcium in the rat pancreatic endocrine cell line, RIN14B [15]. Influx of calcium in response to
Sodium Glucose Transporter 1 activation has previously been shown to contribute to the cytoskeletal
rearrangements that lead to the insertion of GLUT2 (facilitative glucose transporter) in the apical
membrane of enterocytes [28–30]. Further studies are required to ascertain if the calcium influx
induced by TRPA1 activation also initiates similar mechanisms, i.e., increasing absorption of glucose
in enterocytes. Micronutrients that activate TRPA1 have been reported to enhance nutrient handling
efficiency [1–5] and this may be contributed to by a TRPA1-initiated series of events leading to greater
carbohydrate absorption.
5. Conclusions
In conclusion, this study demonstrates functional TRPA1 expression in the mucosa of the small
intestine and colon in mice, and provides a possible explanation of the mechanism through which
phytonutrients acting at TRPA1 affect mucosal function. The data point to the rational use of these
phytonutrients to enhance digestive efficiency.
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